Ya Ruth Huo1, Pushpa Suriyaarachchi2, Fernando Gomez3, Carmen L Curcio3, Derek Boersma4, Piumali Gunawardene2, Oddom Demontiero2, Gustavo Duque5. 1. Faculty of Medicine, University of New South Wales, Kensington, NSW, Australia; Sydney Medical School Nepean, The University of Sydney, Penrith, NSW 2750, Australia. 2. Sydney Medical School Nepean, The University of Sydney, Penrith, NSW 2750, Australia; Department of Geriatric Medicine, Nepean Hospital, Penrith, NSW 2750, Australia. 3. Sydney Medical School Nepean, The University of Sydney, Penrith, NSW 2750, Australia; Department of Geriatric Medicine, Nepean Hospital, Penrith, NSW 2750, Australia; Research Group on Geriatrics and Gerontology, Faculty of Health Sciences, International Association of Gerontology and Geriatrics Collaborative Centre, University of Caldas, Manizales, Colombia. 4. Department of Geriatric Medicine, Nepean Hospital, Penrith, NSW 2750, Australia. 5. Sydney Medical School Nepean, The University of Sydney, Penrith, NSW 2750, Australia; Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, St. Albans, VIC 3021, Australia; Department of Medicine, Melbourne Clinical School - Western Campus, St. Albans, VIC 3021 Australia. Electronic address: gustavo.duque@unimelb.edu.au.
Abstract
BACKGROUND: Although sarcopenic obesity is associated with disability in middle-aged community-dwelling individuals, the phenotype of sarcopenic obesity in people 65 and older, especially those with a history of falls, remain unknown. To fill this knowledge gap, the goal of this study was to obtain a comprehensive phenotype of sarcopenic obesity in this high-risk population. METHODS: Cross-sectional study of 680 subjects (mean age=79±9, 65% female) assessed between 2009 and 2013 at the Falls and Fractures Clinic, Nepean Hospital (Penrith, Australia). The assessment included a comprehensive examination, posturography, gait velocity, grip strength, bone densitometry and body composition by DXA, and blood tests for biochemical status. Patients were divided into four groups based on DXA and clinical criteria: 1) sarcopenic obese; 2) non-sarcopenic obese; 3) sarcopenic and; 4) non-sarcopenic/non-obese. The difference between groups was assessed by one-way ANOVA, chi-square analysis, and multivariable linear regression. RESULTS: Sarcopenic obese subjects were older (81.1±7.3), mostly female and more likely to have lower bone mineral density, lower grip strength, slower gait velocity, and poor balance. Sarcopenic obese individuals also showed significantly higher parathyroid hormone and lower vitamin D. CONCLUSIONS: We identified a particular set of clinical and biochemical characteristics in our subgroup of sarcopenic obese older fallers. Identification of these particular characteristics in the clinical setting is essential in order to prevent poor outcomes in this high-risk population.
BACKGROUND: Although sarcopenic obesity is associated with disability in middle-aged community-dwelling individuals, the phenotype of sarcopenic obesity in people 65 and older, especially those with a history of falls, remain unknown. To fill this knowledge gap, the goal of this study was to obtain a comprehensive phenotype of sarcopenic obesity in this high-risk population. METHODS: Cross-sectional study of 680 subjects (mean age=79±9, 65% female) assessed between 2009 and 2013 at the Falls and Fractures Clinic, Nepean Hospital (Penrith, Australia). The assessment included a comprehensive examination, posturography, gait velocity, grip strength, bone densitometry and body composition by DXA, and blood tests for biochemical status. Patients were divided into four groups based on DXA and clinical criteria: 1) sarcopenic obese; 2) non-sarcopenic obese; 3) sarcopenic and; 4) non-sarcopenic/non-obese. The difference between groups was assessed by one-way ANOVA, chi-square analysis, and multivariable linear regression. RESULTS:Sarcopenic obese subjects were older (81.1±7.3), mostly female and more likely to have lower bone mineral density, lower grip strength, slower gait velocity, and poor balance. Sarcopenic obese individuals also showed significantly higher parathyroid hormone and lower vitamin D. CONCLUSIONS: We identified a particular set of clinical and biochemical characteristics in our subgroup of sarcopenic obese older fallers. Identification of these particular characteristics in the clinical setting is essential in order to prevent poor outcomes in this high-risk population.
Authors: Shawna Follis; Alan Cook; Jennifer W Bea; Scott B Going; Deepika Laddu; Jane A Cauley; Aladdin H Shadyab; Marcia L Stefanick; Zhao Chen Journal: J Am Geriatr Soc Date: 2018-10-30 Impact factor: 5.562
Authors: Fernando Gomez; Carmen Lucia Curcio; Sharon Lee Brennan-Olsen; Derek Boersma; Steven Phu; Sara Vogrin; Pushpa Suriyaarachchi; Gustavo Duque Journal: BMJ Open Date: 2019-07-29 Impact factor: 2.692
Authors: Suey S Y Yeung; Esmee M Reijnierse; Vivien K Pham; Marijke C Trappenburg; Wen Kwang Lim; Carel G M Meskers; Andrea B Maier Journal: J Cachexia Sarcopenia Muscle Date: 2019-04-16 Impact factor: 12.910
Authors: N Hong; E Siglinsky; D Krueger; R White; C O Kim; H C Kim; Y Yeom; N Binkley; Y Rhee; B Buehring Journal: Osteoporos Int Date: 2020-09-07 Impact factor: 4.507